Vanguard Global Advisers’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$95.8K Hold
129,323
– – ﹤0.01% 2794
2026
Q2
$106K Hold
129,323
– – ﹤0.01% 2750
2026
Q1
$119K Buy
+129,323
New +$157K ﹤0.01% 2657

Other funds holding LAB

Vanguard Global Advisers's LAB Position: Q3 2026 in Review

Vanguard Global Advisers held its Standard BioTools (LAB) position steady in Q3 2026 at 129,323 shares worth $95.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

Vanguard Global Advisers first reported a position in LAB in Q1 2026 and has held it in 3 quarters since. The position peaked at $119K in Q1 2026. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

  • Vanguard Global Advisers held 129,323 shares of Standard BioTools worth $95.8K as of Q3 2026.
  • Vanguard Global Advisers left its Standard BioTools share count unchanged in Q3 2026.
  • Standard BioTools made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2794 holding.
  • Vanguard Global Advisers first reported a position in Standard BioTools in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Standard BioTools position peaked at $119K in Q1 2026.
  • 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.